Chemistry Ventures, a venture capital firm established by veterans from prominent VC organisations Bessemer, Index Ventures, and Andreessen Horowitz, is in the process of securing $500 million for its second investment fund. This development, confirmed by an SEC filing, signals significant investor confidence in the firm's strategy, particularly its focus on the burgeoning artificial intelligence sector.
Founded just two years ago, Chemistry Ventures was co-launched by Mark Goldberg, formerly of Index Ventures; Ethan Kurzweil, who previously worked with Bessemer; and Kristina Shen, an alumna of a16z. The trio established the firm with an initial fund of $350 million, aiming to leverage their collective experience from larger venture capital entities to identify and nurture promising early-stage companies.
The firm's investment mandate is squarely centred on artificial intelligence, specifically targeting startups engaged in building both AI infrastructure and applications. Its existing portfolio includes companies such as Granola, Decagon, Persona, Serval, and Nova Intelligence, demonstrating its commitment to pioneering technologies within the AI landscape.
Reports suggest that the fundraising effort for the second fund is already oversubscribed, indicating strong demand from investors keen to tap into the AI market through an experienced management team. The fundraise is anticipated to conclude in the near future, further solidifying Chemistry Ventures' position in the competitive venture capital space.
This significant capital raise underscores the continued appetite for investment in artificial intelligence, a sector that remains a key driver of innovation and economic growth. For UK investors and pension holders, the success of such funds can indirectly contribute to broader market trends and the availability of cutting-edge technologies that may eventually impact various industries and public services.